ATE205072T1 - Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung - Google Patents

Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Info

Publication number
ATE205072T1
ATE205072T1 AT98954562T AT98954562T ATE205072T1 AT E205072 T1 ATE205072 T1 AT E205072T1 AT 98954562 T AT98954562 T AT 98954562T AT 98954562 T AT98954562 T AT 98954562T AT E205072 T1 ATE205072 T1 AT E205072T1
Authority
AT
Austria
Prior art keywords
cosmetic composition
compound
indigotype
composition containing
radical
Prior art date
Application number
AT98954562T
Other languages
English (en)
Inventor
Michel Philippe
Jean-Christophe Henrion
Nathalie Guillier-Berteuil
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE205072T1 publication Critical patent/ATE205072T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
AT98954562T 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung ATE205072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714656A FR2771286B1 (fr) 1997-11-21 1997-11-21 Composition cosmetique comprenant un compose de type indigoide
PCT/FR1998/002411 WO1999026586A1 (fr) 1997-11-21 1998-11-12 Composition cosmetique comprenant un compose de type indigoide

Publications (1)

Publication Number Publication Date
ATE205072T1 true ATE205072T1 (de) 2001-09-15

Family

ID=9513655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954562T ATE205072T1 (de) 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Country Status (10)

Country Link
US (1) US6406685B1 (de)
EP (1) EP1032353B1 (de)
JP (1) JP3572258B2 (de)
AT (1) ATE205072T1 (de)
AU (1) AU1162699A (de)
CA (1) CA2309296C (de)
DE (1) DE69801594T2 (de)
ES (1) ES2163301T3 (de)
FR (1) FR2771286B1 (de)
WO (1) WO1999026586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787023A1 (fr) * 1998-12-11 2000-06-16 Oreal Utilisation d'un compose indigoide dans une composition cosmetique, notamment de maquillage, pour lui conferer des proprietes anti-microbiennes et de longue tenue.
FR2810881B1 (fr) * 2000-06-30 2004-03-26 Lcw Les Colorants Wackherr Composition de laque a usage cosmetique
FR2827506A1 (fr) * 2001-07-20 2003-01-24 Oreal Composition pulverulente et son utilisation en cosmetique
US20030219391A1 (en) * 2002-02-28 2003-11-27 L'oreal Dispersed powders providing ultraviolet light protection, suitable for use in cosmetic compositions
US7534453B1 (en) 2002-09-05 2009-05-19 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles and use in enhancing cell survivability
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
WO2009132277A1 (en) * 2008-04-25 2009-10-29 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
ES2791032T3 (es) 2009-09-02 2020-10-30 Oreal Composición que comprende un colorante hidrófobo, un agente alcalino orgánico y/o mineral particular, un compuesto particular (I) y un compuesto orgánico particular (II), y su utilización en coloración
FR2954120B1 (fr) * 2009-12-18 2012-02-24 Oreal Composition cosmetique comprenant un compose de type indigoide et un compose organique particuliers, et son utilisation en coloration.
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US9867761B2 (en) 2014-04-30 2018-01-16 L Star Softcoat, Llc Colored lamellar compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427888A1 (de) * 1994-08-08 1996-02-15 Linea Conception Software Gmbh Verfahren zum Färben von Haaren
ES2115572T1 (es) * 1996-05-09 1998-07-01 Wella Ag Procedimiento y producto para el teñido del cabello.

Also Published As

Publication number Publication date
AU1162699A (en) 1999-06-15
JP2001523697A (ja) 2001-11-27
FR2771286B1 (fr) 1999-12-31
EP1032353B1 (de) 2001-09-05
DE69801594D1 (de) 2001-10-11
DE69801594T2 (de) 2002-07-11
JP3572258B2 (ja) 2004-09-29
US6406685B1 (en) 2002-06-18
WO1999026586A1 (fr) 1999-06-03
EP1032353A1 (de) 2000-09-06
CA2309296C (fr) 2006-05-23
FR2771286A1 (fr) 1999-05-28
CA2309296A1 (fr) 1999-06-03
ES2163301T3 (es) 2002-01-16

Similar Documents

Publication Publication Date Title
ATE205072T1 (de) Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
FR2674850B1 (fr) Derives s-triaziniques portant des substituants benzalmalonates, compositions cosmetiques filtrantes les contenant et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet.
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
EP0420722A3 (en) Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics
IL108562A (en) 7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c| £1,2,4| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them
MY108076A (en) Cationic compound and cleaning composition.
ZA869497B (en) Antimycotic nail varnish
AU4970390A (en) Cosmetic use of benzotriazole diorganopolysiloxanes and novel cosmetic compositions containing such compounds for the protection of skin and hair
CA2006791A1 (fr) Composition de rasage pour la peau a base de polyorganosiloxanes a fonction acyloxyalkyle et procede de mise en oeuvre
MX9800577A (es) Derivados de 4,5-diaril oxazol.
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
CA2085345A1 (en) Pyrimidine nucleoside derivatives
AU3793589A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69129408D1 (de) 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel
BR9712221A (pt) Uso de pelo menos um 1,3-bis(n-lactamil) propano, composto, e, composições farmacêutica e cosmética.
DE60030553D1 (de) Kosmetische zusammensetzungen
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
ATE22294T1 (de) Pyrido(3,4-c)psoralene, herstellung, verwendung in der kosmetologie und als arzneimittel und diese enthaltende zubereitungen.
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
CS742082A2 (en) Zpusob vyroby substituovanych thiazolidinylesteru mineralnich kyselin
AU3083692A (en) 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylimino/bis(2,4,6-triiod o-1,3-benzenedicarboxyamides), and contrast media containing them
AU2953697A (en) Vitamin d analogs and methods of preparing these compounds
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee